RU98107463A - METHOD FOR INTEGRATED TREATMENT OF PATIENTS WITH tick-borne encephalitis - Google Patents

METHOD FOR INTEGRATED TREATMENT OF PATIENTS WITH tick-borne encephalitis

Info

Publication number
RU98107463A
RU98107463A RU98107463/14A RU98107463A RU98107463A RU 98107463 A RU98107463 A RU 98107463A RU 98107463/14 A RU98107463/14 A RU 98107463/14A RU 98107463 A RU98107463 A RU 98107463A RU 98107463 A RU98107463 A RU 98107463A
Authority
RU
Russia
Prior art keywords
tick
patients
borne encephalitis
borne
treatment
Prior art date
Application number
RU98107463/14A
Other languages
Russian (ru)
Other versions
RU2158606C2 (en
Inventor
Г.М. Воронкова
Т.А. Захарычева
С.П. Николаева
О.В. Мальцева
С.Л. Шарыгин
И.В. Евдокимов
Original Assignee
Хабаровский НИИ эпидемиологии и микробиологии МЗ РФ
Кировский НИИ гематологии и переливания крови
Filing date
Publication date
Application filed by Хабаровский НИИ эпидемиологии и микробиологии МЗ РФ, Кировский НИИ гематологии и переливания крови filed Critical Хабаровский НИИ эпидемиологии и микробиологии МЗ РФ
Priority to RU98107463/14A priority Critical patent/RU2158606C2/en
Priority claimed from RU98107463/14A external-priority patent/RU2158606C2/en
Publication of RU98107463A publication Critical patent/RU98107463A/en
Application granted granted Critical
Publication of RU2158606C2 publication Critical patent/RU2158606C2/en

Links

Claims (1)

Способ комплексного лечения больных клещевым энцефалитом путем введения больному специфических антител против вируса клещевого энцефалита в сочетании с неспецифическими лечебными средствами, отличающийся тем, что, с целью быстрого достижения необходимой концентрации антител в кровяном русле, предотвращения потерь иммунного белка на стадии абсорбции, ускорения наступления ремиссии, сокращения продолжительности лечения в лихорадочной стадии острого периода заболевания вводят внутривенно иммуноглобулин человека против клещевого энцефалита для внутривенного введения, содержащий тормозящие гемагглютинацию антитела в титре не ниже 1:40-1:80 и в дозах, зависящих от формы и тяжести течения инфекции: больным менингеальной формой клещевого энцефалита препарат назначается в разовой дозе 25,0 мл один раз в сутки ежедневно на протяжении до 6 дней, до 150,0 мл на курс; больным очаговыми формами клещевого энцефалита в дозе - 25,0 мл два раза в сутки ежедневно в течение не менее 6 дней, не менее 300,0 мл на курс лечения.A method for the complex treatment of tick-borne encephalitis patients by administering to the patient specific antibodies against tick-borne encephalitis virus in combination with non-specific therapeutic agents, characterized in that, in order to quickly achieve the required concentration of antibodies in the bloodstream, prevent the loss of immune protein at the absorption stage, accelerate the onset of remission, reducing the duration of treatment in the febrile stage of the acute period of the disease, a human immunoglobulin is administered intravenously against tick-borne e cephalitis for intravenous administration, containing hemagglutination inhibiting antibodies in a titer of not less than 1: 40-1: 80 and in doses depending on the form and severity of the infection: the drug is prescribed to patients with meningeal form of tick-borne encephalitis in a single dose of 25.0 ml once a day daily for up to 6 days, up to 150.0 ml per course; patients with focal forms of tick-borne encephalitis at a dose of 25.0 ml twice a day daily for at least 6 days, at least 300.0 ml per treatment course.
RU98107463/14A 1998-04-17 1998-04-17 Complex method for treating the patients suffering from russian tick-borne encephalitis RU2158606C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU98107463/14A RU2158606C2 (en) 1998-04-17 1998-04-17 Complex method for treating the patients suffering from russian tick-borne encephalitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU98107463/14A RU2158606C2 (en) 1998-04-17 1998-04-17 Complex method for treating the patients suffering from russian tick-borne encephalitis

Publications (2)

Publication Number Publication Date
RU98107463A true RU98107463A (en) 2000-02-10
RU2158606C2 RU2158606C2 (en) 2000-11-10

Family

ID=20205015

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98107463/14A RU2158606C2 (en) 1998-04-17 1998-04-17 Complex method for treating the patients suffering from russian tick-borne encephalitis

Country Status (1)

Country Link
RU (1) RU2158606C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2472504C1 (en) * 2012-02-02 2013-01-20 Общество с ограниченной ответственностью Научно-производственное объединение "Перспектива" Pharmaceutical composition for treating tick-borne encephalitis

Similar Documents

Publication Publication Date Title
Doorn et al. High‐dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double‐blind, placebo‐controlled, crossover study
US8815245B2 (en) Method of treating viral diseases
Cherin et al. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients
RU95113492A (en) THERAPEUTIC COMBINATION CONTAINING THE HUMAN INTERFERON, ITS APPLICATION, PHARMACEUTICAL DRUG, PACKAGING AND METHOD OF TREATMENT
Spigset et al. Serotonin syndrome caused by a moclobemide-clomipramine interaction.
Teklu et al. Meptazinol diminishes the Jarisch-Herxheimer reaction of relapsing fever
Buggy et al. Sodium appetite decreased by central angiotensin blockade
RU2002105485A (en) The use of mycophenolate mofetil in combination with PEG-interferon-α (PEG-IFN-α)
PT750514E (en) IMMUNOTHERAPEUTIC PREPARATIONS CONTAINING GAMAGLOBULINS FOR THE TREATMENT OF CANCER DISEASES
RU98107463A (en) METHOD FOR INTEGRATED TREATMENT OF PATIENTS WITH tick-borne encephalitis
JPH01261334A (en) Medical preparation containing angiotensine invertase inhibitor as effective component and production thereof
JP2005529152A5 (en)
Lé Salmonella vertebral osteomyelitis: a case report with literature review
US20020102237A1 (en) Compositions and methods for hepatitis treatment
Shinkawa et al. Depressive state and common cold
RU2196576C1 (en) Method of treatment of patients with hemorrhagic fever and renal syndrome
WAISBREN et al. Antibiotics and gamma-globulin in Pseudomonas infections
RU95112520A (en) APPLICATION 4'-IODO-4'-DEOXIDOXORUBICINE FOR THE TREATMENT OF AMYLOIDOSIS, METHOD OF TREATMENT OF AMYLOIDOSIS
Sarmiento et al. Guillain-Barre syndrome following 2-chlorodeoxyadenosine treatment for Hairy Cell Leukemia
US4990513A (en) Antihypoxic drug and method of its application
JPH0251405B2 (en)
RU2008007C1 (en) Method for treatment of acute hepatitis a infection
Tan et al. Vaccine related glomerulonephritis.
SU1261665A1 (en) Method of treatment of thymomegalia of children
Pernod Hepatic tolerance of ethionamide